Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -57.87 | N/A |
| PEG Ratio (TTM) | 1.04 | N/A |
| P/S Ratio (TTM) | 0.29 | N/A |
| P/B Ratio (TTM) | 1.21 | N/A |
| P/FCF Ratio (TTM) | 29.09 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.87 | N/A |
| Price to 5YR AVG FCF Ratio | 9.03 | N/A |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.88% | N/A |
| ROE (TTM) | -1.92% | N/A |
| Net Profit Margin (TTM) | -0.50% | N/A |
| ROIC 5YR AVG | 7.83% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.64% | 31.47% | -13.86% |
| Revenue | 28.47% | 21.94% | 9.59% |
| Net Income | 21.80% | 31.92% | -13.77% |
| Cash Flow | -774.14% | 1.93% | 422.23% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.44 | N/A |
| Quick Ratio (TTM) | 0.41 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | -1.05 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.71 | N/A |
| LTL to 5YR AVG FCF | 4.90 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.08% | N/A |